HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
Sarah AmeleAnastasia Karachalia SandriAlison J RodgerLinos VandekerckhoveThomas BenfieldAna MilinkovicClaudine DuvivierHans-Jürgen StellbrinkHelen SambatakouNikoloz ChkhartishviliLuis CaldeiraMonserrat LagunoPere DomingoGilles WandelerMartin GisingerElena KuzovatovaGordana DragovicBrygida KnyszRaimonda MatulionyteJürgen Kurt RockstrohJens Dilling LundgrenAmanda MocroftLars Petersnull nullPublished in: HIV medicine (2021)
Among HIV/HCV-coinfected individuals in Europe, 7.3% were reinfected with HCV within 24 months of achieving SVR, with evidence suggesting that this is decreasing over time and with use of newer HCV regimens. Harm reduction to reduce reinfection and surveillance to detect early reinfection with an offer of treatment are essential to eliminate HCV.